2022 Q3 Form 10-K Financial Statement

#000149315222026526 Filed on September 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $311.3K $66.86K $437.1K
YoY Change -95.84% -77.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.450M $1.462M $4.920M
YoY Change 8.82% 26.8% 46.47%
% of Gross Profit
Research & Development $80.00K $692.6K $3.854M
YoY Change -25.09% -46.99% 0.48%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.530M $2.155M $8.774M
YoY Change 6.28% -12.4% 21.95%
Operating Profit -$1.218M -$8.337M
YoY Change -15.35% 49.58%
Interest Expense $0.00 -$90.00 $2.900K
YoY Change -100.0% -103.72% -100.2%
% of Operating Profit
Other Income/Expense, Net $4.294K $2.900K
YoY Change 190.33% -100.2%
Pretax Income -$1.210M -$2.088M -$8.334M
YoY Change -15.85% 145.6% 18.04%
Income Tax
% Of Pretax Income
Net Earnings -$1.208M -$2.078M -$8.306M
YoY Change -15.66% 143.63% 18.03%
Net Earnings / Revenue -388.12% -3108.23% -1900.06%
Basic Earnings Per Share -$0.08 -$0.57
Diluted Earnings Per Share -$1.62 -$139.6K -$566.4K
COMMON SHARES
Basic Shares Outstanding 14.89M shares 14.67M shares
Diluted Shares Outstanding 744.5K shares 733.3K shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.740M $8.238M $8.238M
YoY Change -54.48% -34.48% -34.48%
Cash & Equivalents $5.743M $8.238M
Short-Term Investments
Other Short-Term Assets $148.9K $746.8K $163.1K
YoY Change -93.41% -69.19% -93.27%
Inventory
Prepaid Expenses $41.53K $116.5K
Receivables
Other Receivables $7.050K $25.44K
Total Short-Term Assets $8.207M $10.87M $10.87M
YoY Change -48.25% -40.31% -40.31%
LONG-TERM ASSETS
Property, Plant & Equipment $416.0K $391.4K $391.4K
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $504.9K $0.00
YoY Change 0.19% -100.0%
Total Long-Term Assets $1.952M $1.484M $1.484M
YoY Change -39.88% -59.36% -59.36%
TOTAL ASSETS
Total Short-Term Assets $8.207M $10.87M $10.87M
Total Long-Term Assets $1.952M $1.484M $1.484M
Total Assets $10.16M $12.35M $12.35M
YoY Change -46.83% -43.49% -43.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $380.0K $715.9K $715.9K
YoY Change -38.13% -47.2% -47.2%
Accrued Expenses $960.0K $1.111M $1.111M
YoY Change 199.35% 785.58% 785.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.357M $4.663M $4.663M
YoY Change -16.78% 26.62% 26.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.610M $1.143M $1.143M
YoY Change -5.9% -63.93% -63.93%
Total Long-Term Liabilities $2.610M $1.143M $1.143M
YoY Change -5.9% -63.93% -63.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.357M $4.663M $4.663M
Total Long-Term Liabilities $2.610M $1.143M $1.143M
Total Liabilities $4.964M $5.806M $5.727M
YoY Change -10.56% -14.63% -15.79%
SHAREHOLDERS EQUITY
Retained Earnings -$32.38M -$31.18M
YoY Change 36.32%
Common Stock $148.9K $148.9K
YoY Change 9.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $5.281M $6.625M $6.625M
YoY Change
Total Liabilities & Shareholders Equity $10.16M $12.35M $12.35M
YoY Change -46.83% -43.49% -43.49%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$1.208M -$2.078M -$8.306M
YoY Change -15.66% 143.63% 18.03%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$1.894M -$1.723M -$3.358M
YoY Change -2382.71% 2.18% -70.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$470.0K -$703.0K -$880.2K
YoY Change
Cash From Investing Activities -$474.9K -$703.0K -$880.2K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$1.894M -1.723M -$3.358M
Cash From Investing Activities -$474.9K -703.0K -$880.2K
Cash From Financing Activities 0.000
Net Change In Cash -$2.496M -2.426M -$4.335M
YoY Change 44.11% -135.81%
FREE CASH FLOW
Cash From Operating Activities -$1.894M -$1.723M -$3.358M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001725430
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Auditor Firm
AuditorFirmId
2256
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 GBS Prospectus And Capital Raising Expenses
ProspectusAndCapitalRaisingExpenses
usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2021 GBS Stock Issued During Period Value Cancellation Of Common Stock In Exchange For Preferred Shares
StockIssuedDuringPeriodValueCancellationOfCommonStockInExchangeForPreferredShares
usd
CY2021 GBS Conversion Of Convertible Preferred Shares Into Common Shares At Initial Public Offering
ConversionOfConvertiblePreferredSharesIntoCommonSharesAtInitialPublicOffering
usd
CY2021 GBS Series B Warrants Exercised To Purchase Common Shares
SeriesBWarrantsExercisedToPurchaseCommonShares
usd
CY2021 GBS Conversion Of Convertible Preferred Shares Into Common Shares
ConversionOfConvertiblePreferredSharesIntoCommonShares
usd
CY2022 GBS Series B Warrants Exercised To Purchase Common Shares
SeriesBWarrantsExercisedToPurchaseCommonShares
usd
CY2022 GBS Conversion Of Convertible Preferred Shares Into Common Shares
ConversionOfConvertiblePreferredSharesIntoCommonShares
usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2022 GBS Contingent Beneficial Conversion Feature On Convertible Notes
ContingentBeneficialConversionFeatureOnConvertibleNotes
usd
CY2021 GBS Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
usd
CY2021 GBS Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
usd
CY2021 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
usd
CY2021 GBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022 GBS Reclassification Of Deferred Charges To Additional Paid In Capital Upon Completion Of Initial Public Offering
ReclassificationOfDeferredChargesToAdditionalPaidInCapitalUponCompletionOfInitialPublicOffering
usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2022 GBS Cancellation Of Common Stock In Exchange For Preferred Shares
CancellationOfCommonStockInExchangeForPreferredShares
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q2 GBS Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
usd
CY2021Q2 us-gaap Deposit Assets
DepositAssets
usd
CY2022Q2 GBS Investments In Affiliates Subsidiaries Associates And Joint Ventures Gross
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesGross
usd
CY2022Q2 GBS Loss Income From Affiliate
LossIncomeFromAffiliate
usd
CY2022Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
usd
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
usd
CY2021Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
usd
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2021 GBS Income Tax Reconciliation Benefit Of Federal Operating Loss Carryforwards
IncomeTaxReconciliationBenefitOfFederalOperatingLossCarryforwards
usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39825
CY2022 dei Entity Registrant Name
EntityRegistrantName
GBS Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1512711
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
WeWork c/o GBS Inc.,
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
142 West, 57th Street
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
11th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2022 dei City Area Code
CityAreaCode
(646)
CY2022 dei Local Phone Number
LocalPhoneNumber
828-8258
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
GBS
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
9857116 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14889904 shares
CY2022 dei Auditor Name
AuditorName
BDO Audit Pty Ltd
CY2022 dei Auditor Location
AuditorLocation
Sydney, Australia
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8238301 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12573685 usd
CY2022Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
1529882 usd
CY2021Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
2098884 usd
CY2022Q2 GBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
353048 usd
CY2021Q2 GBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
1025455 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
746761 usd
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2509017 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10867992 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
18207041 usd
CY2022Q2 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1092773 usd
CY2021Q2 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
3148328 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
391408 usd
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
504000 usd
CY2022Q2 us-gaap Assets
Assets
12352173 usd
CY2021Q2 us-gaap Assets
Assets
21859369 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1625089 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1467968 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13323 usd
CY2022Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2836582 usd
CY2021Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2098884 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
201332 usd
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
102475 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4663003 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3682650 usd
CY2022Q2 GBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
50626 usd
CY2021Q2 GBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
21770 usd
CY2022Q2 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
1092773 usd
CY2021Q2 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
3148328 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5806402 usd
CY2021Q2 us-gaap Liabilities
Liabilities
6852748 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1300000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1300000 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
13000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14889904 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14889904 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13582122 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13582122 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
148899 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
135821 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38440011 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38440089 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31175853 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22869803 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-788135 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-661260 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6624922 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15057847 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-79151 usd
CY2021Q2 us-gaap Minority Interest
MinorityInterest
-51226 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15006621 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12352173 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21859369 usd
CY2022 GBS Government Support Income
GovernmentSupportIncome
437146 usd
CY2021 GBS Government Support Income
GovernmentSupportIncome
1980484 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
437146 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1980484 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4920103 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3359065 usd
CY2022 GBS Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
3853919 usd
CY2021 GBS Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
3835703 usd
CY2021 GBS Prospectus And Capital Raising Expenses
ProspectusAndCapitalRaisingExpenses
359198 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
8774022 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
7553966 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8336876 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-5573482 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
7539 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
1093608 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
-135692 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3987 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-271225 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
14426 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
13806 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2900 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1486719 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7060201 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27925 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-22915 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8306051 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7037286 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-126875 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-297309 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-126875 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-297309 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8460851 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7357510 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-27925 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-22915 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8432926 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7334595 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14665263 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10414886 shares
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5214828 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3294745 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21600013 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-3867565 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5133706 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
905948 usd
CY2021 GBS Series A Warrants Exercised To Purchase Common Shares
SeriesAWarrantsExercisedToPurchaseCommonShares
508300 usd
CY2021 GBS Adjustments To Additional Paid In Capital Series And B Warrants Acquired
AdjustmentsToAdditionalPaidInCapitalSeriesAndBWarrantsAcquired
3812 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-297309 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7060201 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15006621 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15006621 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-126875 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7060201 usd
CY2022 GBS Noncash Loss On Foreign Currency Translation Net
NoncashLossOnForeignCurrencyTranslationNet
-3987 usd
CY2021 GBS Noncash Loss On Foreign Currency Translation Net
NoncashLossOnForeignCurrencyTranslationNet
-271225 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-135692 usd
CY2021 GBS Contingent Beneficial Conversion Feature On Convertible Notes
ContingentBeneficialConversionFeatureOnConvertibleNotes
905948 usd
CY2022 GBS Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
2600000 usd
CY2022 GBS Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
50958 usd
CY2022 GBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
8179 usd
CY2021 GBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
66055 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1828891 usd
CY2022 GBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
-672407 usd
CY2021 GBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
1025455 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
333743 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2459955 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
504000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
255978 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
782974 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-13323 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1755970 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
28856 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
21770 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3358034 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11296477 usd
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
500000 usd
CY2022 GBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
380221 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-880221 usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3812 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
508300 usd
CY2021 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
3294745 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
21600013 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2003952 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23402918 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-97129 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39971 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4335384 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12146412 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12573685 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
427273 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8238301 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12573685 usd
CY2021 GBS Reclassification Of Deferred Charges To Additional Paid In Capital Upon Completion Of Initial Public Offering
ReclassificationOfDeferredChargesToAdditionalPaidInCapitalUponCompletionOfInitialPublicOffering
1863613 usd
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5133706 usd
CY2021 GBS Cancellation Of Common Stock In Exchange For Preferred Shares
CancellationOfCommonStockInExchangeForPreferredShares
30000 usd
CY2022 GBS Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
13000 usd
CY2021 GBS Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
45102 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
185301 usd
CY2020Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
17732448 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8306051 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7037286 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2022Q2 GBS Working Capital
WorkingCapital
6204989 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31175853 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
8230000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_ziehcSSIypHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zsKxetonyFIb">Use of estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
24400 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2022 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2100000 usd
CY2022Q2 us-gaap Grants Receivable
GrantsReceivable
2600000 usd
CY2022 GBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
385888 usd
CY2021 GBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
1850175 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
126875 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
297309 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zLgdiIIAB7wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zTmNjSXo4KBc">Concentration of credit risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of the Australia Financial Claims Scheme or the United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i/></b> </span></p>
CY2022Q2 GBS Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
500445 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
116525 usd
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2424143 usd
CY2022Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
57746 usd
CY2021Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
83278 usd
CY2022Q2 us-gaap Deposit Assets
DepositAssets
46602 usd
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
25443 usd
CY2021Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1596 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
746761 usd
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2509017 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
500000 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
500000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.02 pure
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6064025 usd
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5946731 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6064025 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5946731 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
715902 usd
CY2021Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1355894 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
909187 usd
CY2021Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
112074 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1625089 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1467968 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
909187 usd
CY2022 GBS Related Development And Regulatory Approval Expenses
RelatedDevelopmentAndRegulatoryApprovalExpenses
634518 usd
CY2022Q2 GBS Legal And Consulting Fees
LegalAndConsultingFees
136324 usd
CY2022Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
99454 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
38891 usd
CY2021Q2 GBS Investments In Affiliates Subsidiaries Associates And Joint Ventures Gross
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesGross
135692 usd
CY2021Q2 GBS Loss Income From Affiliate
LossIncomeFromAffiliate
-135692 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
782816 usd
CY2022Q2 GBS Percentage Of Reimbursement On Construction Cost
PercentageOfReimbursementOnConstructionCost
0.50 pure
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
782816 usd
CY2022Q2 GBS Percentage Of Reimbursement On Construction Cost
PercentageOfReimbursementOnConstructionCost
0.50 pure
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
391408 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
391408 usd
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6064025 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5946731 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4321600 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4742347 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1682879 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1179984 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
59546 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1770915 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1452905 usd
CY2022 GBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-106634 usd
CY2021 GBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-87360 usd
CY2022 GBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
117039 usd
CY2021 GBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
281730 usd
CY2022 GBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
1643216 usd
CY2021 GBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
-512847 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-117294 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1771382 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
27310563 usd
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
19291293 usd
CY2022 GBS Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
which expire at various dates ranging from 2038 through unlimited expiration
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8306051 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7037286 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14665263 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10414886 shares

Files In Submission

Name View Source Status
0001493152-22-026526-index-headers.html Edgar Link pending
0001493152-22-026526-index.html Edgar Link pending
0001493152-22-026526.txt Edgar Link pending
0001493152-22-026526-xbrl.zip Edgar Link pending
ex10-10.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-6.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
gbs-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
gbs-20220630_pre.xml Edgar Link unprocessable
gbs-20220630_lab.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
gbs-20220630_cal.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gbs-20220630_def.xml Edgar Link unprocessable